BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 5:02:00 PM | Browse: 974 | Download: 1089
 |
Received |
|
2013-10-11 08:44 |
|
Peer-Review Started |
|
2013-10-15 08:31 |
|
To Make the First Decision |
|
2013-10-29 12:32 |
|
Return for Revision |
|
2013-10-30 10:09 |
|
Revised |
|
2013-11-15 10:39 |
|
Second Decision |
|
2013-12-13 14:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2013-12-13 14:57 |
|
Articles in Press |
|
|
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-02-12 12:02 |
|
Publish the Manuscript Online |
|
2014-03-12 11:24 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Immunotherapy in gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Satoko Matsueda and David Y Graham |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Center for Innovative Cancer Therapy, Cancer Vaccine Development Division, Kurume University |
to Matsueda S |
| Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) |
DK067366 (to Graham DY) |
| Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) |
DK56338 (to Graham DY) |
|
| Corresponding Author |
David Y Graham, MD, Michael E DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd, Rm 3A-318B (111D), Houston, TX 77030, United States. dgraham@bcm.edu |
| Key Words |
Gastric cancer; Immune checkpoint; Immune escape; Adoptive cell therapy; Cancer vaccine; Antibody therapy; Predictive biomarker |
| Core Tip |
In the majority of cases gastric cancer is advanced at diagnosis and although medical and surgical treatments have improved, survival rates remain poor. Cancer immunotherapy has emerged as a powerful tool for cancer therapy and has recently shown major success in breast cancer, prostate cancer and melanoma. The field of cancer immunotherapy is in the midst of a huge transition due to the discovery of immunological networks and better understanding of the molecular mechanisms of immunosuppression in the cancer microenvironment. We discuss how immunotherapy will most likely play a major role in the cure of cancer. |
| Publish Date |
2014-03-12 11:24 |
| Citation |
Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol 2014; 20(7): 1657-1666 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i7/1657.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i7.1657 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
